Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
PolyPid Ltd. PYPD
$0.39
-$0 (-0.10%)
На 18:02, 12 мая 2023
+6 310.26%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
15853013.00000000
-
week52high
6.90
-
week52low
0.36
-
Revenue
0
-
P/E TTM
0
-
Beta
1.24601700
-
EPS
-2.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 12:30
Описание компании
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| BMO Capital | Outperform | Outperform | 11 авг 2022 г. |
| Raymond James | Strong Buy | Strong Buy | 11 февр 2022 г. |
| JMP Securities | Market Outperform | 14 сент 2021 г. | |
| Cantor Fitzgerald | Overweight | 30 июл 2021 г. | |
| Alliance Global Partners | Buy | Buy | 10 авг 2020 г. |
| Barclays | Equal-Weight | Overweight | 07 сент 2022 г. |
| Raymond James | Outperform | Strong Buy | 06 сент 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023
GlobeNewsWire
31 янв 2023 г. в 07:00
PETACH TIKVA, Israel, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter and full year 2022 financial results and operational highlights before the open of the U.S. stock markets on Wednesday, February 8, 2023. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.
7 Top Penny Stocks Under $1 To Watch Before Next Week
PennyStocks
26 янв 2023 г. в 12:16
Penny stocks under $1 to watch right now. The post 7 Top Penny Stocks Under $1 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Buy? 4 Under $1 To Watch In January 2023
PennyStocks
24 янв 2023 г. в 09:00
Are these penny stocks under $1 on your watch list this week? The post Best Penny Stocks To Buy?
PolyPid Ltd. (PYPD) Q3 2022 Earnings Call Transcript
Seeking Alpha
12 ноя 2022 г. в 15:29
PolyPid Ltd. (NASDAQ:PYPD ) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ET Company Participants Bob Yedid - Investor Relations, LifeSci Advisors Dikla Czaczkes Akselbrad - Chief Executive Officer Ori Warshavsky - Chief Operating Officer, U.S. Operations Conference Call Participants Brandon Folkes - Cantor Fitzgerald Elliot Wilbur - Raymond James Roy Buchanan - JMP Securities Bob Yedid Thank you all for participating in PolyPid's Third Quarter 2022 Earnings Conference Call.
PolyPid to Report Third Quarter 2022 Financial Results and Operational Highlights on November 9, 2022
GlobeNewsWire
26 окт 2022 г. в 07:00
PETACH TIKVA, Israel, Oct. 26, 2022 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its third quarter 2022 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, November 9, 2022. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.